Want to join the conversation?
Simeon Siegel of Nomura Securities asks about $EXPR's comp expectations. CEO David Kornberg said the company is focused on driving positive comps. The focus is on a balanced approach and ensuring that $EXPR is driving top line growth, margin expansion and expense leverage.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?